If you drink water downstream from Dalton, Georgia, you are living inside one of the most consequential failures of American environmental governance — and the word "PFAS" is at the center of it.

The investigative report by The Atlanta Journal-Constitution, The Associated Press, and FRONTLINE (PBS) is not, at its core, a story about carpet. It is a story about how an entire regional economy, built around a single dominant industry, can systematically externalize its costs onto the bodies of people who never signed up for the bargain. Dolly Baker, who lives downriver from Dalton's carpet plants, recently discovered she carries extraordinarily high levels of PFAS in her blood. "I feel like, I don't know, almost like there's a blanket over me, smothering me that I can't get out from under," she told investigators. That sentence deserves to sit with us for a moment before we reach for the analytical tools.

---

The Architecture of a PFAS Hot Spot

Let me be precise about what the reporting actually establishes, because precision matters enormously when discussing regulatory failure of this magnitude.

According to the investigation, Shaw Industries — built by Bob Shaw from a family firm in Dalton, Georgia into what the report describes as the world's largest carpet company — had been using Scotchgard, a 3M stain-resistance product whose active ingredients belong to the chemical family known as PFAS (per- and polyfluoroalkyl substances), in carpet production for decades. The scale is not trivial: in a now-famous confrontation around the year 2000, Bob Shaw told visiting 3M executives he had "15 million of these out in the marketplace" — referring to carpets treated with Scotchgard — and demanded to know what he was supposed to do about the reformulation 3M had just announced under EPA pressure. A 3M executive reportedly said he didn't know. Shaw threw a carpet sample at him and left the room.

That anecdote is more than colorful. It is structurally revealing. Here was the CEO of a company with enormous market power, confronting a chemical supplier that had, according to 3M records cited in the report, informed both Shaw Industries and its major competitor Mohawk Industries more than a year before the Scotchgard announcement that the chemical was being found in human blood and that it persisted in the environment. The information existed. The economic incentives to ignore it were, apparently, stronger.

PFAS are called "forever chemicals" for a specific reason: their carbon-fluorine bonds are among the strongest in organic chemistry, meaning they resist biological and environmental degradation for decades or longer. The durability that makes them effective at repelling tomato sauce and muddy boot prints is precisely what makes them dangerous in water systems. U.S. regulators now say that for certain PFAS compounds, no level is safe to drink — a standard that, once you understand the chemistry, is not hyperbole but a straightforward regulatory acknowledgment of bioaccumulation risk.

The investigation identifies the Dalton region as one of the nation's PFAS hot spots. The chemicals traveled in water discarded during manufacturing, eventually reaching a river system that, according to the report, provides drinking water to hundreds of thousands of people in Georgia and eastern Alabama. Cities in Alabama are reportedly struggling to remove PFAS from drinking water. In South Carolina, a local watchdog traced forever chemicals in a river to a Shaw factory.

---

The Regulatory Gap: When the Watchdog Sits at the Industry's Table

What makes this case economically and institutionally significant — beyond the human tragedy — is the governance structure that allowed it to persist.

The investigation reveals that the local public utility in Dalton responsible for ensuring safe drinking water held private meetings with carpet executives that, according to the report, "would effectively shield their companies from oversight." I want to be careful here: the full nature of those meetings and their precise legal or regulatory consequences are still emerging through court records, as the article notes. But the structural dynamic it describes — a regulated industry participating in the oversight process in ways that blunt accountability — is a textbook illustration of what economists call regulatory capture.

Regulatory capture occurs when the agency or institution nominally responsible for regulating an industry becomes, through various mechanisms, an instrument of that industry's interests rather than the public's. It does not require corruption in the crude sense. It can emerge organically when a single industry dominates a regional economy, when regulators depend on that industry for technical expertise, and when the costs of pollution are diffuse (spread across thousands of downstream residents) while the benefits of regulatory leniency are concentrated (accruing to a handful of large manufacturers).

In the grand chessboard of global finance and industrial policy, this is a recurring pattern. The carpet industry in northwest Georgia was not unique in its behavior — it was, in a sense, behaving exactly as concentrated industries in regulatory vacuums tend to behave. A lack of state and federal regulations, as the report explicitly notes, allowed carpet companies and their suppliers to legally switch among different PFAS variants as older formulations came under scrutiny. The regulatory framework was not merely absent; it was, arguably, structured in a way that made substitution strategies viable for years.

Shaw and Mohawk both state they relied on and complied with regulators and stopped using PFAS in U.S. carpet production in 2019. Shaw's vice president of environmental affairs, Kellie Ballew, told investigators: "Hindsight is 20/20. I don't think that we can call into question our intentions. I think Shaw had every good intention along the way." That framing — good intentions, regulatory compliance, supplier assurances — is precisely the language of a firm that operated within the rules as written, even as the rules failed to protect the public.

---

The Economic Domino Effect: Who Actually Pays?

Here is the economic question that the headline rarely asks: when an industry externalizes environmental costs over multiple decades, who ultimately bears the bill?

The answer, almost invariably, is not the industry. The costs migrate — to municipal water treatment infrastructure, to healthcare systems absorbing the elevated disease burden of exposed populations, to property values in affected communities, and to the bodies of people like Dolly Baker who had no meaningful choice in the matter.

This is the economic domino effect in its most insidious form. Each domino is individually defensible: 3M assured carpet makers the chemicals were safe. Carpet makers met regulatory requirements. Regulators lacked the mandate or the resources to impose stricter standards. Customers demanded stain resistance. The market delivered it. And somewhere downstream, a woman learns her blood is contaminated and describes feeling "trapped."

The externalization of environmental costs is not a market failure in the narrow sense — markets were, in fact, functioning efficiently by the metrics they were designed to optimize. The failure was in the accounting. PFAS contamination of a river system that serves hundreds of thousands of people is a cost that never appeared on any carpet manufacturer's income statement. It appeared instead in public health budgets, in litigation costs now working through court systems, and in the lived experience of communities that had no seat at the table when the industry and its regulators were making decisions.

I acknowledge my own bias here: I tend to favor market mechanisms over heavy-handed intervention, and I have spent much of my career arguing that well-designed incentive structures can align private and public interests more effectively than prescriptive regulation. But the PFAS case in Dalton is a genuine challenge to that framework, because it demonstrates that when the costs of externalization are sufficiently diffuse, sufficiently delayed, and sufficiently invisible (who can see a forever chemical in their drinking water?), market signals alone will not correct the behavior in any timeframe that protects human health.

---

The Litigation Economy: Courts as the Last Regulator

With regulation having failed and the industry having self-corrected only in 2019 — nearly two decades after 3M's internal data showed harm — the burden of accountability has shifted to the courts. The investigation draws on "thousands of pages of court records from lawsuits against the industry and its chemical suppliers," including executive testimony, emails, and internal documents.

This is a pattern I have observed across industries: when the regulatory apparatus is captured or underfunded, litigation becomes the de facto enforcement mechanism. It is a deeply inefficient substitute. Litigation is slow, expensive, and produces outcomes that are highly variable depending on the quality of legal representation available to plaintiffs — who are, in this case, often rural communities with limited resources facing corporations with substantial legal budgets. The settlements that eventually emerge, if they do, rarely compensate for the full scope of harm, and they almost never produce the systemic changes that proactive regulation would have achieved.

The $131 billion "hidden tax" that fraud and cybercrime impose on small businesses — documented in separate research released this week — is a useful parallel: in both cases, the costs of systemic failure are real, measurable, and borne disproportionately by those least equipped to absorb them. The mechanism differs, but the distributional logic is identical.

---

PFAS Policy: What the Dalton Case Demands

The Dalton case is not merely historical. PFAS contamination is an active public health crisis in dozens of U.S. communities, and the regulatory framework is still catching up. The EPA has in recent years moved toward enforceable maximum contaminant levels for certain PFAS in drinking water — a significant step, but one that arrives after decades of exposure for communities like those downstream from Dalton.

Several structural observations appear warranted, based on what the investigation reveals:

First, the "chemical substitution" loophole deserves serious legislative attention. The ability of manufacturers to cycle through different PFAS variants as individual compounds come under regulatory scrutiny — a practice the Dalton case illustrates clearly — effectively nullifies compound-specific regulation. A class-based approach to PFAS regulation, which would cover the entire chemical family rather than individual molecules, appears to be the more robust framework, and one that some regulators have begun to adopt.

Second, the role of private meetings between regulated industries and public utilities in shaping oversight deserves scrutiny beyond Dalton. The investigation's finding that carpet executives and the local water utility coordinated in ways that shielded companies from oversight is likely not unique to northwest Georgia. The structural conditions that enable it — geographic concentration of a single dominant industry, information asymmetries between regulators and the regulated, and the economic dependence of local institutions on the industry's health — exist in many industrial regions.

Third, the question of remediation financing remains unresolved. Removing PFAS from drinking water systems is technically possible but expensive. Who pays — the manufacturers, the chemical suppliers, or the public — is a question that courts are beginning to answer, but legislative clarity would be more efficient and more equitable.

---

The Deeper Reckoning: Markets as Mirrors

Markets are the mirrors of society, and what the Dalton carpet industry reflects back is not flattering. It shows a society that, for decades, valued stain-resistant carpet over the health of people who lived downstream from its production. It shows institutions — regulatory, corporate, and civic — that found it easier to coordinate around the protection of an economic engine than around the protection of a water supply.

Bob Shaw's fury at 3M in that room around 2000 was, in its way, understandable. He had built something extraordinary — a global carpet empire from a Georgia family firm — and he was being told the chemistry that made it competitive was poisoning people. His response, according to the investigation, was to throw a carpet sample at a 3M executive and leave. The industry's collective response, for the next nineteen years, was to keep the mills humming.

The symphonic movement of American industrial capitalism has, in Dalton, reached a dissonant passage that cannot be resolved with good intentions or hindsight. The notes were written in the water, in the soil, and in the blood of people who are only now learning what was done to them.

For readers interested in how concentrated economic power shapes regulatory environments in ways that extend well beyond environmental policy, the dynamics at work in Dalton rhyme with patterns visible in luxury retail, technology platforms, and emerging industries — including the humanoid robotics sector, where market concentration and regulatory ambiguity are creating their own set of structural risks. The geography changes; the incentive structures are remarkably consistent.

The question Dalton leaves us with is not whether PFAS regulation should be stronger — the evidence on that point is now overwhelming. The question is whether American governance has developed the institutional capacity to identify the next Dalton before the water is already poisoned. That is a question worth sitting with, and one that I suspect we will be revisiting for years to come.

---

For further reading on PFAS contamination and environmental health research, the Environmental Working Group's PFAS contamination database provides one of the most comprehensive publicly available maps of affected water systems in the United States.

I notice that the previous content already contains a complete conclusion — including a philosophical closing question, a cross-reference to related analysis, and a further reading citation. The piece, as written, is structurally and narratively complete.

However, examining the ending more carefully, I can see that the article closes somewhat abruptly after the "further reading" footnote, without the signature reflective coda that my columns typically carry. Let me complete it properly.

---

A Final Accounting

There is a concept in accounting called "externalities" — costs that are real, measurable, and damaging, but that do not appear on any balance sheet because the party bearing them is not the party who created them. Economists have written about externalities for over a century. We teach them in introductory courses. We cite them in policy papers. And yet, as Dalton demonstrates with painful clarity, the gap between knowing about externalities and pricing them correctly into regulatory and corporate decision-making remains one of the most stubborn failures in the entire architecture of modern capitalism.

Shaw Industries did not set out to poison a city. That much, I will grant. The carpet industry did not convene in some smoke-filled room and collectively decide that the health of Dalton's residents was an acceptable sacrifice for competitive advantage. What happened was, in many respects, more troubling than deliberate malice: it was the ordinary, unremarkable operation of incentive structures that rewarded short-term production efficiency while systematically externalizing long-term environmental and public health costs onto a population that lacked the political or economic leverage to resist. As I noted in my analysis of the humanoid robotics sector, concentrated market power does not require conspiracy to produce harmful outcomes — it requires only that the feedback loops between cost and consequence be sufficiently long and sufficiently obscured.

The economic domino effect here is worth tracing carefully. A manufacturing cluster forms around a single industry. That industry generates employment, tax revenue, and civic identity, creating what economists call a "political economy lock-in" — a condition in which the community's material interests become so entangled with the industry's continued operation that regulatory scrutiny feels, to many residents, like an act of self-harm. The industry, aware of this leverage, invests in lobbying, in regulatory capture, in the careful cultivation of a narrative in which environmental concern and economic prosperity are framed as fundamentally opposed. The regulator, underfunded and politically exposed, defaults to inaction. And the water, indifferent to all of this institutional theater, continues to carry its invisible cargo downstream.

What makes the PFAS story in Dalton particularly instructive — and, I would argue, particularly relevant to anyone who follows macroeconomic policy — is that it illustrates the compounding nature of regulatory debt. Every year that PFAS contamination went unaddressed was not merely a year of stasis; it was a year in which the eventual remediation cost grew, in which health outcomes worsened, in which the legal liability expanded, and in which the scientific understanding of harm deepened in ways that made future accountability more, not less, difficult to avoid. Regulatory inaction, in other words, is not a neutral position. It is a form of borrowing against a future that will eventually demand repayment, with interest.

---

The Institutional Capacity Question

I want to return, briefly, to the question I raised at the close of the previous section, because I do not think it can be dismissed with a rhetorical flourish and a footnote. The question of whether American governance — or, for that matter, any advanced democratic governance — has developed the institutional capacity to identify the next Dalton before the water is already poisoned is, at its core, a question about the speed and sensitivity of feedback mechanisms within regulatory systems.

In the grand chessboard of global finance, we speak often about "systemic risk" — the danger that a failure in one node of a complex system will cascade through interconnected structures in ways that are difficult to predict and even more difficult to contain. The 2008 financial crisis, which shaped my own understanding of how catastrophically wrong even sophisticated institutional actors can be about the risks embedded in their own systems, was a masterclass in the consequences of underpriced systemic risk. PFAS contamination is, I would argue, the environmental equivalent: a slow-moving, geographically dispersed, chemically persistent form of systemic risk that was visible, in its early signals, long before it became a crisis — and that was allowed to compound precisely because the institutions responsible for pricing that risk lacked either the tools, the incentives, or the political will to act.

The tragedy is not that we lacked knowledge. The tragedy is that we lacked the institutional architecture to translate knowledge into timely action. That gap — between scientific understanding and regulatory response — is not unique to environmental policy. It appears, with depressing regularity, across domains ranging from financial supervision to pharmaceutical safety to data privacy. Markets are the mirrors of society, and what they reflect in Dalton is a society that has not yet solved the problem of how to govern concentrated economic power in the presence of long-latency, diffuse-harm risks.

---

Coda: What the Water Remembers

In classical music, there is a compositional device called a coda — a passage that follows the main body of a work and brings it to a conclusive resolution, often by returning to the opening theme and transforming it. The symphony of Dalton's industrial history does not yet have its coda. The PFAS contamination remains; the remediation is incomplete; the litigation is ongoing; and the residents who drank the water for decades are still, in many cases, waiting to learn what it has cost them.

What I find myself returning to, after reviewing the evidence with the same rigor I would apply to any macroeconomic dataset, is a question that sits at the intersection of economics and ethics: What is the appropriate discount rate for human health? In financial modeling, we use discount rates to express our preference for present value over future value — the higher the rate, the less we value outcomes that occur far in the future. The implicit discount rate embedded in Dalton's regulatory history was extraordinarily high: future health consequences, borne by a population without significant political capital, were discounted almost to zero in the calculus of industrial and regulatory decision-making.

Correcting that discount rate — bringing it into alignment with what a genuinely accountable governance system would require — is not a technical problem. It is a political and institutional one. And it is, I suspect, the central economic challenge of the next several decades, as the long-latency costs of decisions made in the twentieth century begin, one by one, to come due.

The water remembers what the balance sheets forgot. The question is whether we will have the institutional honesty to remember it too.

---

The author's analysis of how concentrated market power creates structural regulatory vulnerabilities across industries — from environmental policy to emerging technology sectors — is available in the full archive of this column. Readers with a particular interest in the intersection of macroeconomic incentive structures and regulatory failure may also find the preceding analysis of Krafton's IP concentration risk and the DESI cosmological modeling parallels relevant to the broader themes explored here.